Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Company Information
About this company
Key people
Key facts
- Shares in issue33.13m
- EPICPPGN
- ISINCH1110760852
- LocationSwitzerland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capCHF 1.46bn
- Employees1,460
- ExchangeSIX Swiss Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.